Last reviewed 2026-04-20 · How we verify

Metformin HCl and Vascepa

Thetis Pharmaceuticals LLC · Phase 1 active Small molecule Quality 0/100

Metformin HCl and Vascepa is a Small molecule drug developed by Thetis Pharmaceuticals LLC. It is currently in Phase 1 development.

At a glance

Generic name	Metformin HCl and Vascepa
Sponsor	Thetis Pharmaceuticals LLC
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Metformin HCl and Vascepa CI brief — competitive landscape report
Metformin HCl and Vascepa updates RSS · CI watch RSS
Thetis Pharmaceuticals LLC portfolio CI

Frequently asked questions about Metformin HCl and Vascepa

What is Metformin HCl and Vascepa?

Metformin HCl and Vascepa is a Small molecule drug developed by Thetis Pharmaceuticals LLC.

Who makes Metformin HCl and Vascepa?

Metformin HCl and Vascepa is developed by Thetis Pharmaceuticals LLC (see full Thetis Pharmaceuticals LLC pipeline at /company/thetis-pharmaceuticals-llc).

What development phase is Metformin HCl and Vascepa in?

Metformin HCl and Vascepa is in Phase 1.

Manufacturer: Thetis Pharmaceuticals LLC — full pipeline
Compare: Metformin HCl and Vascepa vs similar drugs
Pricing: Metformin HCl and Vascepa cost, discount & access